Projects per year
Personal profile
Education
- 2008-2015 Ph.D, Taiwan International Graduate Program-The Molecular Medicine Program, Academia Sinica and National Yang Ming University
- 1996-2003 M.D.,College of Medicine, Taipei Medical University
Experience
- 2023- Adjoint Associate Professor, Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA
- 2023- Associate Professor (Joint Appointment), Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
- 2023- Associate Professor (Joint Appointment), Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan
- 2023- Associate Professor, School and College of Medicine, Taipei Medical University, Taipei, Taiwan
- 2021- Director, Center for Precision Health and Quantitative Sciences, Taipei Medical University Hospital, Taipei, Taiwan
- 2020- Attending Physician, Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan
- 2022 Coordinator, Precision Oncology Team, Taipei Medical University
- 2021-2023 Associate Director, Department of Medical Research, Taipei Medical University Hospital, Taipei, Taiwan
- 2021-2023 Assistant Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2021-2022 Director, Center for Precision Medicine and Translational Cancer Research, Taipei Medical University Hospital, Taipei, Taiwan
- 2020-2023 Adjoint Assistant Professor, Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA
- 2020 Assistant Professor, College of Medicine, Fu Jen Catholic University
- 2020 Attending Physician of Chest Medicine and Director of Medical Research, Fu Jen Catholic University Hospital, New Taipei City, Taiwan
- 2018-2020 Visiting Scholar, Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA
- 2015-2019 Attending Physician, Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan
- 2015-2018 Adjunct Attending Physician, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
- 2008-2019 Adjunct Attending Physician, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
- 2006-2008 Clinical Fellow, Division of Chest Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
- 2003-2006 Resident, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
- 2002-2003 Rotating Intern, National Taiwan University Hospital, Taipei, Taiwan
Awards
- 2024 TOS Young Investigator Award for Cancer Research, Taiwan.
- 2022 Outstanding Research Award, Taipei Medical University, Taipei, Taiwan
- 2020 VICTR award. Vanderbilt University Medical Center, Nashville, TN, USA.
- 2019 Fellowship award, Method in Clinical Cancer Research. Zeist, Netherland.
- 2019 Fellowship award, IASLC Targeted Therapies of Lung Cancer Meeting. Santa Monica, CA, USA.
- 2016 Young investigator communication workshop award. WCLC. Vienna, Austria.
- 2011 Outstanding presentation award. Joint Molecular Medicine Program Retreat. Institute of Biomedical Sciences, Academia Sinica, Taiwan
- 2009 Fellowship award, Molecular Biology in Clinical Oncology. Aspen, CO, USA.
- 2009 AACR-ITO EN, Ltd. Scholar-in-Training Award. The 100th AACR Annual Meeting. Denvor, CO, USA.
- 2003 Dr. Tu Tsung-Ming award
Research Interests
- Internal Medicine
- Pulmonary and Critical Care Medicine
- Thoracic Oncology
- Cancer Biology and Molecular Cancer Biology
- Translational Cancer Research
- Precision Medicine and Precision Oncology
Fingerprint
Dive into the research topics where Emily Pei-Ying Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Reshaping Tumor Microenvironment in Lung Cancer: Turning Cold into Hot
Lin, E.P.-Y. (PI)
8/1/23 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Overcoming Barriers in Lung Cancer Therapy: Delivery, Targeting, and Resistance
Lin, E.P.-Y. (PI)
8/1/22 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
針對表皮生長因子受體研發肺癌治療之抑制型胜肽藥物
Lin, E.P.-Y. (PI)
1/1/23 → 12/31/23
Project: A - Government Institution › a - National Health Research Institutes
-
針對表皮生長因子受體研發肺癌治療之抑制型胜肽藥物
Lin, E.P.-Y. (PI)
1/1/22 → 12/31/22
Project: A - Government Institution › a - National Health Research Institutes
-
2-1-3 精進核心研究服務平台-研究型主治醫師林佩瑩
Lin, E.P.-Y. (PI)
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
-
Analysis of Cancer Survival Associated with Immune Checkpoint Inhibitors after Statistical Adjustment: A Systematic Review and Meta-analyses
Lin, E. P. Y., Hsu, C. Y., Berry, L., Bunn, P. & Shyr, Y., Aug 17 2022, In: JAMA network open. 5, 8, p. E2227211Research output: Contribution to journal › Review article › peer-review
Open Access15 Citations (Scopus) -
Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors
Lin, E. P. Y., Huang, L. C., Whisenant, J., York, S., Osterman, T., Lewis, J., Iams, W., Skotte, E., Cass, A., Hsu, C. Y., Shyr, Y. & Horn, L., Oct 1 2022, In: ERJ Open Research. 8, 4, 00684-2021.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit
Lin, E. P. Y., Hsu, C. Y., Chiou, J. F., Berry, L., Horn, L., Bunn, P., Yang, J. C. H., Yang, P. C., Adjei, A. A. & Shyr, Y., Dec 2022, In: Journal of Thoracic Oncology. 17, 12, p. 1365-1374 10 p.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Development and Evaluation of a Method to Correct Misinterpretation of Clinical Trial Results with Long-term Survival
Hsu, C. Y., Lin, E. P. Y. & Shyr, Y., 2021, (Accepted/In press) In: JAMA oncology. 7, 7, p. 1041-1044 4 p.Research output: Contribution to journal › Article › peer-review
11 Citations (Scopus) -
PINK1-mediated inhibition of EGFR dimerization and activation impedes EGFR-driven lung tumorigenesis
Emily Pei-Ying Lin, P.-Y. L., Huang, B. T., Lai, W. Y., Tseng, Y. T., Yang, S. C., Kuo, H. C. & Yang, P. C., Apr 2021, In: Cancer Research. 81, 7, p. 1745-1757 13 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)